NYSE:BDX

Becton Dickinson stock jumps 5% as BDX rebounds from forecast reset

Becton, Dickinson and Company shares jumped 5.2% to $180.62 in after-hours trading Wednesday after cutting its 2026 adjusted earnings forecast following the Waters deal. First-quarter revenue reached $5.25 billion, with adjusted EPS at $2.91. Trading volume nearly tripled its 50-day average. Investors remain focused on margins amid China pricing pressure, tariffs, and the Alaris pump cycle.

11 February 2026

NYSE:BDX·Stock Market

BD Stock Slides After Waters Deal Closes: Why BDX’s 2026 Profit View Changed

Becton, Dickinson and Company shares fell 1.2% to $207.39 in after-hours trading after it cut its 2026 profit outlook following the spin-off of its Biosciences & Diagnostic Solutions unit to Waters. BD shareholders received 0.135 Waters shares per BD share. The new 2026 adjusted EPS forecast of $12.35–$12.65 is well below prior guidance and Wall Street estimates. Waters shares dropped 14%.

9 February 2026

NYSE:BDX·NYSE:WAT·Stock Market

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Dow futures rose 46 points premarket Monday, while S&P 500 and Nasdaq 100 futures slipped ahead of Wednesday’s delayed January jobs report and Friday’s CPI. Hims & Hers shares fell 14.8% premarket after scrapping plans for a $49 weight-loss pill; Novo Nordisk jumped over 8% in Copenhagen. Treasury buyback details and Fed speeches are due later today.

9 February 2026

Federal Reserve·NYSE:APO·NYSE:BDX·NYSE:KD·NYSE:L·Stock Market

Shocking CFO Departure Sends BDX Stock Tumbling — But Growth Remains Strong

BD said CFO Chris DelOrefice will step down Dec. 5, 2025, with Vitor Roque named interim CFO. Preliminary Q4 revenue rose 8.3% to $5.9 billion, but shares fell 5.8% after hours as U.S. regulators opened a medical-device import probe. FY2025 adjusted EPS is expected at or above guidance midpoint. Analysts’ consensus price target is $205–217.

16 October 2025

NYSE:BDX

Is Rubrik (RBRK) Undervalued Amid Recent Share Price Drop?
March 19, 2026, 11:56 PM EDT. Rubrik's share price fell 34.9% over three months, closing at $50.92, sparking debate about its valuation. Analysts estimate Rubrik's fair value at $100.52, suggesting it is potentially undervalued by about 28%. Despite the steep drop, its price-to-sales (P/S) ratio stands at 7.7x, higher than the US Software average of 3.5x, hinting at premium valuation and limited margin for error if growth expectations miss. Key factors include revenue growth, margin improvements, and product positioning, balanced against competition and potential setbacks in cyber resilience spending. Investors are urged to weigh these aspects carefully amid mixed signals from price trends and analyst forecasts.